Acutus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	20.16	7.16	3.03	17.26	8.46
Revenue Growth (YoY)	181.37%	136.36%	-82.44%	103.96%	198.45%
Cost of Revenue	19.14	10.3	4.94	32.93	15.89
Gross Profit	1.01	-3.14	-1.91	-15.66	-7.43
Selling, General & Admin	10.44	14.07	20.32	63.52	50.36
Research & Development	-	3.48	3.12	36.68	33.45
Operating Expenses	10.44	17.55	23.43	100.21	83.81
Operating Income	-9.42	-20.69	-25.34	-115.87	-91.24
Interest Expense	-5.76	-5.66	-5.15	-5.68	-5.51
Interest & Investment Income	0.76	2.59	0.87	0.12	0.44
Other Non Operating Income (Expenses)	0.52	2.94	0.03	-	-5.56
EBT Excluding Unusual Items	-13.9	-20.82	-29.59	-121.43	-101.86
Merger & Restructuring Charges	-1.45	-	-	-	-
Impairment of Goodwill	-	-	-12.03	-	-
Gain (Loss) on Sale of Assets	10.81	9.08	79.47	-	-
Other Unusual Items	-	-0.12	-9	3.75	-0.1
Pretax Income	-4.54	-11.86	28.85	-117.68	-101.96
Income Tax Expense	-	0.06	0.02	-	0.02
Earnings From Continuing Operations	-4.54	-11.92	28.83	-117.68	-101.98
Earnings From Discontinued Operations	-5.01	-69.74	-68.45	-	-
Net Income	-9.55	-81.66	-39.62	-117.68	-101.98
Net Income to Common	-9.55	-81.66	-39.62	-117.68	-101.98
Shares Outstanding (Basic)	30	29	28	29	11
Shares Outstanding (Diluted)	30	29	37	29	11
Shares Change (YoY)	2.31%	-21.69%	29.66%	151.19%	1597.67%
EPS (Basic)	-0.32	-2.81	-1.39	-4.11	-8.94
EPS (Diluted)	-0.32	-2.81	-1.06	-4.11	-8.94
Free Cash Flow	-31.77	-63.34	-89.15	-109.66	-96.39
Free Cash Flow Per Share	-1.07	-2.18	-2.40	-3.83	-8.45
Gross Margin	5.03%	-43.79%	-63.02%	-90.73%	-87.72%
Operating Margin	-46.75%	-288.74%	-836.13%	-671.19%	-1077.93%
Profit Margin	-47.36%	-1139.91%	-1307.03%	-681.71%	-1204.88%
Free Cash Flow Margin	-157.62%	-884.10%	-2941.11%	-635.20%	-1138.87%
EBITDA	-9.13	-20.49	-24.78	-109.47	-88.02
EBITDA Margin	-45.27%	-286.07%	-	-	-
D&A For EBITDA	0.3	0.19	0.56	6.39	3.22
EBIT	-9.42	-20.69	-25.34	-115.87	-91.24
EBIT Margin	-46.75%	-288.74%	-	-	-
Effective Tax Rate	-	-	0.05%	-	-

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.